Pharmacy Society of Wisconsin
Registered Principal Details
Business Or Interest:
Pharmacy, pharmacists, pharmacy technician, student pharmacists, schools of pharmacy, pharmaceuticals, healthcare
Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy residents, pharmacy businesses, medication usage, medication costs, prescription drug use, medication use and abuse, and the practice of pharmacy.
CEO Name:
Sarah Sorum
Pharmacy, pharmacists, pharmacy technician, student pharmacists, schools of pharmacy, pharmaceuticals, healthcare
Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy residents, pharmacy businesses, medication usage, medication costs, prescription drug use, medication use and abuse, and the practice of pharmacy.
CEO Name:
Sarah Sorum
Contact
DMW
Danielle M Womack
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 8
Relating to: agreements for direct primary care.
Bill Text and History
2/10/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: agreements for direct primary care.
Bill Text and History
For
Notification Date2/10/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 43
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
For
Notification Date3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 68
Relating to: the prescription drug monitoring program. (FE)
Bill Text and History
3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the prescription drug monitoring program. (FE)
Bill Text and History
For
Notification Date3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 104
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.
Bill Text and History
3/12/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting gender transition medical intervention for individuals under 18 years of age.
Bill Text and History
Against
Notification Date3/12/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 127
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
Bill Text and History
3/12/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
Bill Text and History
Against
Notification Date3/12/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/15/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date4/15/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 432
Relating to: transparency and regulation of prior authorization requirements under health insurance plans. (FE)
Bill Text and History
9/17/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: transparency and regulation of prior authorization requirements under health insurance plans. (FE)
Bill Text and History
Undisclosed
Notification Date9/17/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 4
Relating to: agreements for direct primary care.
Bill Text and History
2/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: agreements for direct primary care.
Bill Text and History
For
Notification Date2/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 42
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
2/13/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
For
Notification Date2/13/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 68
Relating to: the prescription drug monitoring program. (FE)
Bill Text and History
2025 Wisconsin Act 5
3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the prescription drug monitoring program. (FE)
Bill Text and History
2025 Wisconsin Act 5
For
Notification Date3/6/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 137
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
Bill Text and History
5/20/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
Bill Text and History
Against
Notification Date5/20/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 203
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
7/29/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date7/29/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 367
Relating to: virtual credit card payments in health insurance policies.
Bill Text and History
10/22/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: virtual credit card payments in health insurance policies.
Bill Text and History
For
Notification Date10/22/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 534
Relating to: regulating medical cannabis, the prescription drug monitoring program, and providing a penalty. (FE)
Bill Text and History
10/22/2025
First Communication Date
10/22/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Supporting Documentation
10222025_082849_Cannabis Testimony_PSW.pdf
Relating to: regulating medical cannabis, the prescription drug monitoring program, and providing a penalty. (FE)
Bill Text and History
Other
Notification Date10/22/2025
First Communication Date
10/22/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Supporting Documentation
10222025_082849_Cannabis Testimony_PSW.pdf
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Corrections: Departmentwide
Corrections: Departmentwide
Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services
Health Services: Medicaid Services
Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide
Insurance: Departmentwide
Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Departmentwide
Safety and Professional Services: Departmentwide
Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Professional Regulation and Administrative Services
Safety and Professional Services: Professional Regulation and Administrative Services
Notification Date
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/24/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Administrative Rulemaking Proceedings
Agency Name
Pharmacy Examining Board (Phar)
Subject
Compounding pharmaceuticals
Scope Statement
SS 007_23
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Compounding pharmaceuticals
Scope Statement
SS 007_23
Other
Notification Date1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Controlled substances requirements
Scope Statement
SS 044_23
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Controlled substances requirements
Scope Statement
SS 044_23
For
Notification Date1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Electronic prescriptions, prescription labeling, CPR for pharmacists, epinephrine delivery systems, controlled substance prescription transfers, remote dispensing, managing pharmacist definition, initial consultation, alteration, and final check
Agency Name
Pharmacy Examining Board (Phar)
Subject
Electronic prescriptions, prescription labeling, CPR for pharmacists, epinephrine delivery systems, controlled substance prescription transfers, remote dispensing, managing pharmacist definition, initial consultation, alteration, and final check
Scope Statement
SS 089_24
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Electronic prescriptions, prescription labeling, CPR for pharmacists, epinephrine delivery systems, controlled substance prescription transfers, remote dispensing, managing pharmacist definition, initial consultation, alteration, and final check
Scope Statement
SS 089_24
Undisclosed
Notification Date1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Pharmacy workplace conditions
Scope Statement
SS 002_25
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Pharmacy workplace conditions
Scope Statement
SS 002_25
Undisclosed
Notification Date1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Access to opioid reversal agents
Access to opioid reversal agents
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/31/2025
First Communication Date
1/28/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
1/31/2025
First Communication Date
1/28/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacist prescribing of contraception
Pharmacist prescribing of contraception
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmacy practice
Pharmacy practice
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
PBM reform
PBM reform
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
1/14/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
1/14/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Total Lobbying Effort
| 2025 January - June |
Total | |
|---|---|---|
| Total Lobbying Expenditures | 2025 January - June $72,510.36 |
Total $72,510.36 |
| Total Hours Communicating | 2025 January - June 132.25 |
Total 132.25 |
| Total Hours Other | 2025 January - June 356.00 |
Total 356.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 5% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 5% |
Relating to: permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 5% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 5% |
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 10% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 10% |
Relating to: the duty of a pharmacist to dispense lawfully prescribed drugs and devices. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 10% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 10% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 25% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 25% |
Budget Bill Subjects
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 5% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 5% |
Administrative Rulemaking Proceedings
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 5% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 5% |
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 10% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 10% |
Topics Not Yet Assigned A Bill Or Rule Number
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 20% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 20% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication